0000914190-18-000348.txt : 20180821 0000914190-18-000348.hdr.sgml : 20180821 20180821162352 ACCESSION NUMBER: 0000914190-18-000348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180817 FILED AS OF DATE: 20180821 DATE AS OF CHANGE: 20180821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILLUND LAURA CENTRAL INDEX KEY: 0001241101 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 181030558 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-08-17 0001180145 Cardiovascular Systems Inc CSII 0001241101 GILLUND LAURA 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 0 1 0 0 Chief Talent Officer Common Stock 2018-08-17 4 S 0 2147 37.5555 D 87705 D In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.44 to $37.6694 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 273 shares acquired on December 31, 2017 and 946 shares acquired on June 30, 2018 through the Issuer's Employee Stock Purchase Plan. /s/ Amanda Lorentz as Attorney-in-Fact for Laura Gillund pursuant to Power of Attorney previously filed. 2018-08-21